SandboxAQ brings its drug discovery models to Claude — no PhD in computing required
SandboxAQ has partnered with Anthropic to integrate its drug discovery AI models into Claude, allowing users to access powerful tools without needing specialized computing skills. The company aims to simplify the drug discovery process, which is traditionally expensive and time-consuming. By focusing on user accessibility, SandboxAQ hopes to transform the quantitative economy with its unique physics-grounded models.
- ▪SandboxAQ has raised over $950 million and was founded as an Alphabet spinout.
- ▪The company's large quantitative models are designed to run quantum chemistry calculations and simulate molecular dynamics.
- ▪SandboxAQ's integration with Claude allows users to interact with AI models using natural language.
TechCrunch files mainly under tech. We currently carry 596 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | TechCrunch |
| Canonical URL | https://techcrunch.com/2026/05/18/sandboxaq-brings-its-drug-discovery-models-to-claude-no-phd-in-computing-required/ |
| Publication time | Mon, 18 May 2026 21:29:31 +0000 |
| Retrieval time | 2026-05-18T21:34:56.992Z |
| Last seen | 2026-05-18T21:34:56.992Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | OZhuoUGRWKJg |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Drug discovery is one of the most expensive failures in modern industry. Finding a single viable molecule can take a decade and cost billions, and most candidates still don’t make it. A generation of AI startups has promised to fix that — most have made the problem less painful for researchers who are already technically sophisticated enough to use the tools. But SandboxAQ thinks the bottleneck isn’t the models. It’s the interface. The company has teamed up with Anthropic to integrate its scientific AI models directly into Claude — putting powerful drug discovery and materials science tools behind a conversational interface that requires no specialized computing infrastructure to use.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at TechCrunch.
Discussion
0 commentsMore from TechCrunch
